Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions

The coronavirus disease 2019 (COVID-19) (caused by severe acute respiratory syndrome coronavirus 2) pandemic has massively distorted our health care systems and caused catastrophic consequences in our affected communities. The number of victims continues to increase, and patients at risk can only be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Allergy Clin Immunol
Main Authors: Valent, Peter, Akin, Cem, Bonadonna, Patrizia, Brockow, Knut, Niedoszytko, Marek, Nedoszytko, Boguslaw, Butterfield, Joseph H., Alvarez-Twose, Ivan, Sotlar, Karl, Schwaab, Juliana, Jawhar, Mohamad, Reiter, Andreas, Castells, Mariana, Sperr, Wolfgang R., Kluin-Nelemans, Hanneke C., Hermine, Olivier, Gotlib, Jason, Zanotti, Roberta, Broesby-Olsen, Sigurd, Horny, Hans-Peter, Triggiani, Massimo, Siebenhaar, Frank, Orfao, Alberto, Metcalfe, Dean D., Arock, Michel, Hartmann, Karin
Formato: Artigo
Idioma:Inglês
Publicado em: The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7297685/
https://ncbi.nlm.nih.gov/pubmed/32561389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2020.06.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados